Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Important genomic factors for SM progression

Brian Walker • 13 Sep 2019
IMW 2019
Multiple Myeloma

Brian Walker, PhD, University of Arkansas for Medical Sciences, Little Rock, AR, speaking from the International Myeloma Workshop (IMW) 2019, held in Boston, MA, discusses the primary genomic factors that contribute to the progression of smoldering myeloma (SM).

More from Brian Walker

The future of myeloma therapy
Brian Walker et al. • 15 Apr 2023
2:00
An update on the genomic landscape of MM
Brian Walker • 15 Sep 2019
0:42
Non-coding mutations impact gene expression in myeloma
Brian Walker • 13 Sep 2019
12:00
Re-evaluating the role of epigenetics in multiple myeloma
Brian Walker et al. • 18 Oct 2017

Related Videos

4:59
MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meeting
Ola Landgren • 13 Apr 2024
1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals